Trial
NCT01209832
A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Advanced Cancer
Intervention
Tasisulam
Why stopped
Terminated based on safety results from another trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-18